The Effect of Electrode Implantation for Deep Brain Stimulation (DBS) on Brain Function Using Single Photon Emission Computed Tomography (SPECT) With Technetium-99m-ethyl Cysteinatedimer (Tc-ECD)

Sponsor
Sheba Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT01037686
Collaborator
(none)
120
1
1
56
2.1

Study Details

Study Description

Brief Summary

The goal of this study is to explore the effect of subthalamic nucleus (STN)-DBS surgery and stimulation in PD (Parkinson's disease) patients on regional cerebral blood (CBF) flow during cognitive task performance or at rest.

Condition or Disease Intervention/Treatment Phase
  • Radiation: Injection of 15mCi of Tc-ECD and scanning by SPECT camera
  • Behavioral: Semantic verbal fluency task performance
  • Device: Turning off the stimulator
N/A

Detailed Description

In this study subjects undergo SPECT scans for CBF mapping. PD patients before the surgery and healthy controls undergo two scans. PD patients after the surgery undergo four scans. PD patients who undergo two scans before the surgery, undergo only two scans after the surgery.

Uptake of Tc-ECD, a CBF radiotracer, is done in the following conditions:
  • For PD patients before the surgery - during the performance of the semantic verbal fluency task or at rest (total of 2 scans).

  • For PD patients after the surgery- during the performance of the semantic verbal fluency task or at rest, either at on-stimulation or off-stimulation condition (total of 4 scans). The stimulator is turned off by the neurologist for 10 min.

  • PD patients before and after the surgery- during performance of the semantic verbal fluency task or at rest before the surgery and during performance of the semantic verbal fluency task or at rest after the surgery only at off-stimulation condition (Total of 4 scans).

  • Healthy controls - during the performance of the semantic verbal fluency task or at rest (total of 2 scans).

Following the Tc-ECD injection, the subjects are scanned by Irix SPECT camera for 15min.

Scans are analyzed and the regional CBF is measured using imaging software. Statistical analysis is done to discover the effect of the surgery, stimulation and the disease on blood flow at rest and during task performance. In addition, differences between groups in number of words produced during the task are also statistically analyzed.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Exploring the Effect of Electrode Implantation for DBS on Brain Function During Rest and During Semantic Verbal Fluency Task Using SPECT With Tc-ECD
Study Start Date :
Feb 1, 2006
Anticipated Primary Completion Date :
Apr 1, 2010
Anticipated Study Completion Date :
Oct 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Other: PD, DBS, healthy controls

Patients with idiopathic PD before or after DBS surgery (during on or off-stimulation) and healthy controls.

Radiation: Injection of 15mCi of Tc-ECD and scanning by SPECT camera
All subjects (PD patients with or without DBS and healthy controls) will be injected with 15mCi of Tc-ECD and afterwards will be scanned by an Irix SPECT camera.

Behavioral: Semantic verbal fluency task performance
All Subjects (PD patients with or without DBS and healthy controls) before one of the two scans will perform the semantic verbal fluency task during the Tc-ECD uptake for 9 minutes. Before the other scan subjects will be at rest.

Device: Turning off the stimulator
For PD patients treated with DBS, the neurologist will turn off the stimulator after the injection of Tc-ECD for ten minutes and then turn it back on.

Outcome Measures

Primary Outcome Measures

  1. CBF values in different brain regions [3 months to 2 years post-surgery]

Secondary Outcome Measures

  1. Number of words produced in the semantic fluency task [3 months to 2 years post-surgery]

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Progressive idiopathic PD

  • For control group - age-matched to study groups

Exclusion Criteria:
  • Progressive dementia or other psychiatric disorders

  • Other neurological conditions

  • Other physical disease

  • Intolerance of "off stimulation" state

  • Involuntary head motions

  • Hearing deficits

Contacts and Locations

Locations

Site City State Country Postal Code
1 Movement Disorders Clinic, Sheba Medical Center Ramat Gan Israel 52621

Sponsors and Collaborators

  • Sheba Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01037686
Other Study ID Numbers:
  • SHEBA-05-3972-SH-CTIL
First Posted:
Dec 23, 2009
Last Update Posted:
Dec 23, 2009
Last Verified:
Dec 1, 2009
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 23, 2009